Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

66.16
Delayed Data
As of Feb 24
 +0.31 / +0.47%
Today’s Change
49.63
Today|||52-Week Range
66.16
+12.38%
Year-to-Date
Billionaire Carl Icahn Is Reportedly Buying Bristol-Myers Squibb Stock -- Should You?
11:44am / MotleyFool.com - Paid Partner Content
Cramer: Buyers for Bristol-Myers Are Few and Far Between
Feb 22 / TheStreet.com - Paid Partner Content
Merck Takes $2.9 Billion Charge on Dampened Outlook for Hepatitis Drug
Feb 24 / TheStreet.com - Paid Partner Content
Bristol Myers' Future Unsure as Carl Icahn Takes Stake
Feb 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, No...
Feb 24 / Zacks.com - Paid Partner Content
House Border Tax Plan Could Make Travel Abroad Cheaper for Americans
Feb 22 / TheStreet.com - Paid Partner Content
Why 3D Printing and Biotech Will Be Good Bets in 2017
Feb 23 / GuruFocus News - Paid Partner Content
Can Carl Icahn Save Bristol Myers Squibb?
Feb 21 / Zacks.com - Paid Partner Content
Trump Meets With Top CEOs To Brainstorm "Jump-Starting" US Economy, Creating Jobs
Feb 23 / Investing Channel - Paid Partner Content
Bristol-Myers Buys Back Shares, Shuffles Board
Feb 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close65.85
Today’s open65.65
Day’s range65.63 - 66.16
Volume8,444,253
Average volume (3 months)11,025,544
Market cap$182.4B
Dividend yield2.84%
Data as of 4:01pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+30.77%
Earnings growth (this year)+1.05%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)+2.67%
P/E ratio33.8
Price/Sales4.12
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.17-0.22%
PFEPfizer+0.20+0.59%
SNYSanofi+0.19+0.45%
GSKGlaxoSmithKline+0.07+0.17%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.8B
Annual profit (last year)$5.7B
Net profit margin14.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs